rel="nofollow" href="#ulink_5ab32311-7786-5c7c-ab5a-54702b7e1ebd">12.2 Physician and health professional education program
12.3 Mechanism to monitor blood use and adherence to guidelines
12.4 Preoperative Anemia
12.5 Preoperative autologous blood donation
12.6 Acute normovolemic hemodilution
12.7 Intraoperative blood salvage
12.8 Postoperative blood salvage
12.9 Use of hemostatic agents to minimize transfusion
12.10 Limiting blood loss for laboratory testing
12.11 Directed‐donor blood
12.12 Patient‐specific donation
12.13 Minimal donor exposure programs
References
18 13 Pediatric Transfusion Medicine 13.1 Neonates 13.2 Pediatric patients 13.3 Modifications of blood products for neonates/children 13.4 Transfusion techniques in children and neonates 13.5 Special scenarios in pediatric transfusion medicine References
19 14 Pathogen Reduced Blood Products 14.1 Pathogen Reduction Technologies 14.2 Toxicity of compounds used for pathogen inactivation 14.3 Immunologic effects 14.4 Factors that influence transmission of infection 14.5 Microbial killing capacity of pathogen reduction therapy technologies 14.6 Pathogen reduced blood products 14.7 Pathogen reduced platelet products 14.8 Red cells and whole blood 14.9 Conclusions from in vitro and animal and observational human studies 14.10 Clinical trials of pathogen reduced components References
20 15 Techniques of Blood Transfusion 15.1 Obtaining consent for transfusion 15.2 Venous access and the venipuncture 15.3 Transportation and storage of blood 15.4 Identification of the patient and blood component 15.5 Blood administration sets and filters 15.6 Infusion Devices 15.7 Infusion solutions 15.8 Starting the transfusion 15.9 Rate and duration of transfusion 15.10 Nursing care of patients receiving a transfusion 15.11 Transfusion techniques for neonates and infants 15.12 Transfusion of hematopoietic stem cell products 15.13 Transfusion in the nonhospital setting References
21 16 Complications of Transfusion 16.1 Immunologic complications of transfusion resulting in transfusion reactions 16.2 Nonimmunologic hemolysis mimicking a transfusion reaction 16.3 Febrile nonhemolytic transfusion reactions 16.4 Allergic reactions 16.5 Pulmonary reactions, acute lung injury, and transfusion‐related acute lung injury 16.6 Anaphylactic reactions 16.7 Hypotensive reactions 16.8 Reactions to platelet transfusions 16.9 Reactions to granulocyte transfusions 16.10 Reactions due to bacterial contamination of blood components 16.11 Signs, symptoms, and management of a transfusion reaction 16.12 Immunologic complications of transfusion 16.13 Nonimmunologic complications of blood transfusion 16.14 Passive transfer of hypersensitivity References
22 17 Transfusion‐Transmitted Diseases 17.1 Syphilis 17.2 Hepatitis 17.3 HIV infection and AIDS 17.4 Other transfusion‐transmitted viruses 17.5 Transfusion‐transmitted
